Bosentan (under the brand name Tracleer by Actelion Pharmaceuticals) is the first approved endothelian receptor antagonist. It was approved by the FDA in November 2001 and is used in the treatment of Pulmonary Arterial Hypertension.
More information
More information
Sites 2
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations
Features an overview of pulmonary hypertension, prescribing information for US residents, and press releases.
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations
Features an overview of pulmonary hypertension, prescribing information for US residents, and press releases.
